ICU Medical (ICUI)
(Delayed Data from NSDQ)
$107.10 USD
+0.72 (0.68%)
Updated May 10, 2024 04:00 PM ET
After-Market: $107.24 +0.14 (0.13%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for ICU Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -29.66 | -74.29 | 103.14 | 86.87 | 101.04 |
Depreciation/Amortization & Depletion | 235.61 | 268.91 | 90.59 | 95.08 | 85.63 |
Net Change from Assets/Liabilities | -135.60 | -303.73 | 15.04 | -16.97 | -111.64 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 95.85 | 46.98 | 58.77 | 57.77 | 26.89 |
Net Cash From Operating Activities | 166.20 | -62.13 | 267.54 | 222.75 | 101.92 |
Property & Equipment | -82.39 | -89.32 | -68.32 | -85.83 | -97.28 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1,844.16 | -14.45 | 0.00 | -76.13 |
Investments | 4.22 | 33.04 | 4.72 | -3.93 | 15.25 |
Other Investing Activities | -9.78 | -9.02 | -12.63 | -8.39 | -8.73 |
Net Cash from Investing Activities | -87.95 | -1,909.47 | -90.69 | -98.14 | -166.89 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.02 | 8.79 | 9.37 | 13.19 | -10.91 |
Issuance (Repayment) of Debt | -30.65 | 1,641.31 | -0.61 | -0.36 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -9.35 | -13.06 | -25.64 | -12.88 | 0.00 |
Net Cash from Financing Activities | -35.98 | 1,637.03 | -16.87 | -0.04 | -10.91 |
Effect of Exchange Rate Changes | 3.16 | -9.48 | -3.25 | 2.85 | -0.23 |
Net Change In Cash & Equivalents | 45.44 | -344.04 | 156.73 | 127.43 | -76.11 |
Cash at Beginning of Period | 208.78 | 552.83 | 396.10 | 268.67 | 344.78 |
Cash at End of Period | 254.22 | 208.78 | 552.83 | 396.10 | 268.67 |
Diluted Net EPS | -1.23 | -3.11 | 4.74 | 4.02 | 4.69 |
Fiscal Year End for ICU Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -29.66 | -12.51 | -19.75 | -9.81 |
Depreciation/Amortization & Depletion | NA | 235.61 | 176.74 | 116.66 | 57.45 |
Net Change from Assets/Liabilities | NA | -135.60 | -149.66 | -111.95 | -29.84 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 95.85 | 60.36 | 54.81 | 23.44 |
Net Cash From Operating Activities | NA | 166.20 | 74.93 | 39.77 | 41.25 |
Property & Equipment | NA | -82.39 | -52.48 | -31.06 | -14.15 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 4.22 | 2.92 | 2.92 | 1.50 |
Other Investing Activities | NA | -9.78 | -7.74 | -4.65 | -2.53 |
Net Cash from Investing Activities | NA | -87.95 | -57.30 | -32.79 | -15.18 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 4.02 | 4.02 | 2.23 | 0.17 |
Issuance (Repayment) of Debt | NA | -30.65 | -22.93 | -15.25 | -7.58 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -9.35 | -9.22 | -8.72 | -8.43 |
Net Cash from Financing Activities | NA | -35.98 | -28.13 | -21.73 | -15.84 |
Effect of Exchange Rate Changes | NA | 3.16 | -1.10 | 1.86 | 1.94 |
Net Change In Cash & Equivalents | NA | 45.44 | -11.59 | -12.90 | 12.16 |
Cash at Beginning of Period | NA | 208.78 | 208.78 | 208.78 | 208.78 |
Cash at End of Period | NA | 254.22 | 197.19 | 195.89 | 220.95 |
Diluted Net EPS | NA | -0.71 | 0.30 | -0.41 | -0.41 |